3/7/24 16:12 | 3/5/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.d | 0 | 0.00 | 0 | 82 | 27 | 383 | D | | | | | | | | | | | | | | |
3/7/24 16:12 | 3/5/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | S.d | -1,352 | 13.52 | 0 | -100 | -21 | 383 | D | | | | | | | | | | | | | | |
3/5/24 16:12 | 3/3/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.dm | 0 | 0.00 | 0 | 58 | 17 | 401 | D | | | | | | | | | | | | | | |
3/1/24 06:52 | 2/28/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.d | 0 | 0.00 | 0 | 21 | 6 | 342 | D | | | | | | | | | | | | | | |
3/7/23 16:11 | 3/4/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.dm | 0 | 0.00 | 0 | 73 | 29 | 322 | D | | | | | | | | | | | | | | |
3/2/23 07:36 | 2/28/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.d | 0 | 0.00 | 0 | 71 | 40 | 248 | D | | | | | | | | | | | | | | |
3/8/22 16:11 | 3/4/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.dm | 0 | 0.00 | 0 | 83 | 88 | 178 | D | | | | | | | | | | | | | | |
3/2/22 07:50 | 2/28/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.d | 0 | 0.00 | 0 | 21 | 28 | 95 | D | | | | | | | | | | | | | | |
2/10/22 16:10 | 2/9/22 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | EVP,Inte | M.d | 0 | 0.00 | 0 | 16 | 27 | 74 | D | | | | | | | | | | | | | | |